Evrofarma SA (EVRr)

Athens

Currency in EUR

EVRr Pro Research

3.640

+0.050(+1.39%)

Delayed Data·08:04:26

Fair Value

Unlock Value

Day's Range

3.530

3.680

52 wk Range

2.380

4.070

EVRr Income Statement

Assess the Evrofarma SA income statement, providing a detailed view of the company’s financial performance across activities. This statement outlines key financial figures such as revenue, expenses, operating income, and net income. Assess the EVRr net worth.

Period Ending:

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

2024

31/12

2025

31/12

Total Revenues

aa.aa

36.7

45.38

48.76

45.72

49.44

Total Revenues Growth

aa.aa

+8.23%

+23.66%

+7.45%

-6.24%

+8.14%

Cost Of Revenues

aa.aa

32.86

39.59

41.7

36.99

38.92

Gross Profit

aa.aa

3.84

5.8

7.06

8.73

10.52

Gross Profit Growth

aa.aa

-23%

+50.95%

+21.81%

+23.69%

+20.54%

Gross Profit Margin %

aa.aa

10.46%

12.77%

14.48%

19.1%

21.29%

Other Operating Expenses, Total

aa.aa

3.61

3.54

3.4

5.93

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+2.79%	-1.91%	-3.81%	+47%	+18.49%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	4.73	4.69	4.64	6.09	6.83
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-1.12	-1.15	-1.24	-1.09	-0.9

Operating Income

aa.aa

0.23

2.26

3.66

3.73

4.6

Operating Income Growth

aa.aa

-84.35%

+876.62%

+62.01%

+1.97%

+23.29%

EBIT Margin %

aa.aa

0.63%

4.97%

7.5%

8.15%

9.29%

Net Interest Expenses

aa.aa

-0.78

-0.84

-1.32

-1.1

-0.61

Net Interest Expenses Growth

aa.aa

+4.29%

-7.95%

-56.77%

+16.44%

+45.06%

Interest Expense, Total

aa.aa

-0.78

-0.84

-1.32

-1.1

-0.65

Interest And Investment Income

aa.aa

0.04

Other Non Operating Expenses, Total

aa.aa

0.01

-0.05

-0.02

-0.09

EBT, Excl. Unusual Items

aa.aa

-0.54

1.36

2.32

2.54

3.9

Gain (Loss) On Sale Of Assets

aa.aa

0.02

0.05

Other Unusual Items, Total

aa.aa

0.3

0.16

0.39

0.33

0.58

EBT, Incl. Unusual Items

aa.aa

-0.26

1.52

2.71

2.89

4.53

EBT, Incl. Unusual Items Growth

aa.aa

-122.15%

+685.38%

+77.86%

+6.69%

+56.72%

EBT, Incl. Unusual Items Margin

aa.aa

-0.71%

3.35%

5.55%

6.32%

9.15%

Income Tax Expense

aa.aa

0.1

0.51

0.61

Net Income to Company

aa.aa

-0.36

1.42

2.2

2.28

3.53

Minority Interest

aa.aa

Net Income

aa.aa

-0.36

1.42

2.2

2.28

3.53

Net Income Growth

aa.aa

-133.52%

+499.72%

+55.18%

+3.54%

+54.65%

Net Income Margin %

aa.aa

-0.97%

3.13%

4.52%

4.99%

7.13%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

-0.36

1.42

2.2

2.28

3.53

Basic EPS - Continuing Operations

aa.aa

-0.03

0.1

0.16

0.17

0.26

Basic EPS - Continuing Operations Growth

aa.aa

-133.52%

+499.8%

+55.11%

+3.57%

+54.65%

Diluted EPS - Continuing Operations

aa.aa

-0.03

0.1

0.16

0.17

0.26

Diluted EPS - Continuing Operations Growth

aa.aa

-133.52%

+499.8%

+55.11%

+3.57%

+54.65%

Basic Weighted Average Shares Outstanding

aa.aa

13.67

13.68

13.67

Diluted Weighted Average Shares Outstanding

aa.aa

13.67

13.68

13.67

Dividend Per Share

aa.aa

0.05

0.06

Dividend Per Share Growth

aa.aa

+20%

EBITDA

aa.aa

1.63

3.75

5.31

5.49

6.54

EBITDA Growth

aa.aa

-42.02%

+129.44%

+41.69%

+3.43%

+19.11%

EBITDA Margin %

aa.aa

4.45%

8.26%

10.89%

12.02%

13.24%

EBIT

aa.aa

0.23

2.26

3.66

3.73

4.6

* In Millions of EUR (except for per share items)

FAQ

What was Evrofarma SA’s revenue at year end?

At the end of the last reported fiscal year, Evrofarma SA (EVRr) recorded total revenue of 49.442 million EUR.

How much revenue did Evrofarma SA report in the most recent quarter?

In its most recent quarterly earnings report, Evrofarma SA posted revenue of 25.118 million EUR.

What was Evrofarma SA’s net income for the year?

For the full year, Evrofarma SA reported net income of 3.526 million EUR.

How much net income did Evrofarma SA post in the last quarter?

In the most recent quarter, Evrofarma SA (EVRr) posted net income of 1.715 million EUR.

What was Evrofarma SA’s gross profit for the year?

Gross profit for the year was reported at 10.524 million EUR.

How much gross profit did Evrofarma SA generate last quarter?

Evrofarma SA recorded gross profit of 5.135 million EUR in its latest quarterly report.

What was Evrofarma SA’s annual operating income?

For the full year, Evrofarma SA (EVRr) reported operating income of 4.595 million EUR.

What was Evrofarma SA’s operating income last quarter?

Quarterly operating income was 2.045 million EUR.

What was Evrofarma SA’s quarterly EBITDA?

In the latest quarter, EBITDA was reported at 3.190 million EUR.

What was the quarter-over-quarter change in EBITDA for Evrofarma SA?

EBITDA changed by -4.890% million EUR compared to the last quarter.

How did Evrofarma SA’s revenue change compared to the previous quarter?

Revenue changed by 3.264% million EUR compared to the prior quarter.

What was the quarter-over-quarter change in gross profit for Evrofarma SA?

In the latest quarter, gross profit changed by -4.713% million EUR from the previous quarter.

S&P/TSX

35,444.49

-123.65

-0.35%

S&P/TSX 60

2,094.09

-5.34

-0.25%

US 30

52,521.50

+311.8

+0.60%

US 500

7,407.00

-6.2

-0.08%

S&P 500 VIX

19.07

+0.40

+2.14%

DAX

25,342.46

-81.95

-0.32%

Dollar Index

101.364

-0.020

-0.02%

Market Movers

Name	Last	Chg. %	Vol.
RBC	293.19	-0.99%	2.21M
Bank of Montreal	249.05	-1.22%	2.45M
Shopify Inc	183.68	+2.53%	147.39K
Toronto Dominion Bank	167.34	-0.91%	102.47K
Bank of Nova Scotia	121.76	-0.74%	102.49K
Celestica Inc.	462.17	+2.82%	25.01K
Canadian Natural	63.29	+0.05%	175.24K

Name	Last	Chg. %	Vol.
Lomiko Metals	0.1250	+66.67%	366.85K
Diagnos	0.345	+43.75%	503.19K
Mcf Energy	0.02	+33.33%	2.00K
Millennium Silver	0.020	+33.33%	2.19K
Oceanic Wind Energy	0.1150	+27.78%	3.50K
GT Resources	0.0300	+20.00%	29.56K
RecycLiCo Battery Materials	0.0650	+18.18%	144.96K

Name	Last	Chg. %	Vol.
Absolutely	0.015	-25.00%	5.00K
Star Diamond	0.020	-20.00%	12.29K
Earthworks Industries	0.0200	-20.00%	20.60K
Canstar	0.050	-16.67%	17.93K
Fintech Select	0.0250	-16.67%	2.70K
Sable Resources	0.0500	-16.67%	28.76K
Orestone Mining	0.0750	-16.67%	4.34K

Trending Stocks

Name	Last	Chg. %	Vol.
Celestica Inc.	462.17	+2.82%	25.01K
Keel Infra	5.28	-7.85%	334.36K
TELUS	14.90	+1.43%	467.42K
Toronto Dominion Bank	167.34	-0.91%	102.47K
Canadian Natural	63.29	+0.05%	175.24K

Most Undervalued Stocks

Name	Last	Upside	Fair Value
A Aaa A Aa Aaaaaaa	6.46	+59.61%	10.31
Aa Aaaa Aaaaaa Aaa	99.78	+55.38%	155.04
Aaaaaaaaaaaaaaa	0.45	+45.64%	0.66
A Aaaaaaa	5.36	+43.56%	7.69
A Aaaaaaaaa	17.66	+42.47%	25.16
Aaaaaaaa Aaaaa	17.00	+41.03%	23.98
A Aaaaaaaaa	34.00	+38.75%	47.17

Name	Last	Upside	Fair Value
A Aaa A Aa Aaaaaaa	6.46	+59.61%	10.31
Aa Aaaa Aaaaaa Aaa	99.78	+55.38%	155.04
Aaaaaaaaaaaaaaa	0.45	+45.64%	0.66
A Aaaaaaa	5.36	+43.56%	7.69
A Aaaaaaaaa	17.66	+42.47%	25.16
Aaaaaaaa Aaaaa	17.00	+41.03%	23.98
A Aaaaaaaaa	34.00	+38.75%	47.17

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Popular Searches

Please try another search

Evrofarma SA (EVRr)

EVRr Income Statement

FAQ

What was Evrofarma SA’s revenue at year end?

How much revenue did Evrofarma SA report in the most recent quarter?

What was Evrofarma SA’s net income for the year?

How much net income did Evrofarma SA post in the last quarter?

What was Evrofarma SA’s gross profit for the year?

How much gross profit did Evrofarma SA generate last quarter?

What was Evrofarma SA’s annual operating income?

What was Evrofarma SA’s operating income last quarter?

What was Evrofarma SA’s quarterly EBITDA?

What was the quarter-over-quarter change in EBITDA for Evrofarma SA?

How did Evrofarma SA’s revenue change compared to the previous quarter?

What was the quarter-over-quarter change in gross profit for Evrofarma SA?

Trending Stocks